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Adriamycin under partially anaerobic conditions degrades deoxyribose with the release of thiobarbituric 
acid-reactive products. This reaction is seen when electrons are transferred to adriamycin by xanthine 
oxidase or ferredoxin reductase to form the semiquinone free radical. Under the conditions described, 
damage to deoxyribose was inhibited by hydroxyl radical scavengers, catalase and iron chelators. When 
the ratio of iron chelator to iron salt is varied both EDTA and diethylenetriamino penta-acetic acid 
(DETAPAC) show stimulatory properties whereas desferrioxamine remains a potent inhibitor of all 
reaction. 
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1. INTRODUCTION 
Adriamycin, a member of the anthracycline an- 
titumour antibiotics, is widely used in modern 
cancer therapy. Its mode of action is believed to 
relate to its ability to intercalate with cell DNA. In 
addition, it has been observed to cause strand 
scissons in closed covalent circular DNA [ 1,2]. 
Damage in this system is thought to result from the 
formation of hydroxyl radicals (OH; ) by an ‘iron- 
catalysed Haber-Weiss reaction’ initiated by reduc- 
ed adriamycin transferring electrons to dioxygen to 
form superoxide radicals (0; -) [3]. 
A novel reaction has been described in which the 
adriamycin semiquinone free radical (Ad’ -) is 
thought to react directly with hydrogen peroxide to 
form the hydroxyl radical (OH ‘) [4]. Both xan- 
thine oxidase and ferredoxin reductase provide 
simple systems for directly transferring electrons to 
a variety of quinone-containing agents such as 
adriamycin, to form their semiquinone radicals 
[5,6]. When dioxygen is present, however, 
superoxide radicals will form the major radical 
species: 
Ad’- +Oz-‘O;- +Ad (1) 
The sugar moiety of DNA, deoxyribose, is par- 
ticularly susceptible to OH ’ radical damage when 
these are generated in close proximity to it; a reac- 
tion which readily occurs when the antitumour an- 
tibiotic bleomycin binds to DNA in the presence of 
dioxygen and a reduced iron salt. This damage can 
be measured by the release of thiobarbituric acid- 
reactive (TBA) products [7,8]. In a similar way, 
deoxyribose has been shown to release TBA- 
reactive material following incubation with a 
reduced iron salt [9,10]. This latter technique pro- 
vides a sensitive method for detecting the occur- 
rence of OH ’ radical damage [l l] and has there- 
fore been applied to our studies with adriamycin. 
2. METHODS AND MATERIALS 
Superoxide dismutase (bovine erythrocyte, 3000 
units/ml), catalase (bovine liver, 27000 units/ml, 
xanthine oxidase (grade 1,28.1 units/ml), albumin 
(human, fatty acid free), transferrin (human, iron 
free), ferredoxin-NADP+ reductase (2.4 units/ 
mg), 2-deoxy-D-ribose, diethylenetriaminopenta- 
acetic acid, NADPH, allopurinol, and hypoxan- 
thine were obtained from Sigma Chemical Co. All 
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units of enzyme activity were as defined in the 
Sigma catalogue. Desferrioxamine (Desferal) was 
from Ciba-Geigy and adriamycin (doxorubicin hy- 
drochloride) from Farmitalia Carlo Erba. d% nm 
showed the sample to be -70% pure. All other 
chemicals used were of the highest grades available 
and obtained from BDH. All solutions were 
prepared in Chelex resin-treated istilled water. 
2.1. D&gradation of deoxyribose 
(A) Xanthine oxidase system: 0.4 ml deoxyribose 
(5 mM), 0.4 ml aqueous saturated hypoxanthine 
and 10~1 adriamycin (1 mg/ml) were placed in a 
new clean glass tube, 9 x 1.5 cm, with a tight- 
fitting screw cap. Where appropriate, inhibitors 
were added at the final reaction concentrations in- 
dicated in table 1. Tubes for incubation under 
nitrogen were gassed for 1 min and immediately 
capped; tubes for incubation in air were left open 
to the normal laboratory atmosphere; 0.07 units of 
xanthine oxidase (grade I) were added to each tube 
and the contents incubated at 37°C for 30 mn. The 
pH of the mixture was 6.9. 
(B) Ferredoxin reductase system: 0.4ml deox- 
yribose (5 mM), 0.2ml phosphate-saline buffer 
(pH7.4) (0.024M phosphate, 0.15 M NaCl), 10~1 
adriamycin and 0.2 ml NADPH 1.6mM were 
treated as above with inhibitors and nitrogen gas. 
This was followed by the addition of 0.8ml fer- 
redoxin reductase (1 unit/ml) and incubated at 
37°C for 1 h, both in air and under nitrogen. 
(C) Measurement of TBA-reactivity: After in- 
cubation, 0.5 ml, 2.8% (w/v) trichloroacetic acid 
and 0.5 ml 1% thiobarbituric acid in 0.05 M NaOH 
was added to each tube before heating at 100°C for 
15 min. The resulting pink chromogen was 
measured at 532nm against appropriate blanks. 
Table I 
Degradation of deoxyribose by adriamycin using the enzyme system xanthine oxidase and hypoxanthine 
Inhibitors added to the reaction Amount of TBA-reactive material formed from deoxy- 
ribose in 0.5 h (A532) 
In air Under nitrogen 
A532 Inhib. A532 Inhib. 
70 070 
Blank 1 (no XOD) 0.05 0.06 
Blank 2 (no adriamycin) 0.38 0.30 
Control (all reagents) 0.48 1.40 
+ EDTA 0.1 mM 0.31 40 0.38 76 
+ DETAPAC 0.1 mM 0.12 84 0.21 89 
+ Desferrioxamine 0.1 mM 0.16 74 0.13 95 
+ Transferrin 0.1 mg/ml 0.26 51 0.25 86 
+ Albumin 0.1 mg/ml 0.49 0 1.26 10 
+ Superoxide dismutase 
(0.05 mg/ml) 0.20 65 1.28 9 
+ Catalase 0.1 mg/ml 0.15 77 0.09 98 
+ Catalase (boiled) 0.43 12 1.13 20 
+ Mannitol 10 mM 0.24 56 0.35 78 
+ Thiourea 1 mM 0.30 42 0.78 46 
+ Allopurinol 0.10 88 0.32 81 
The % inhibition is calculated after subtraction of As32 given by the chromogenic properties of adriamycin 
(i.e., blank no. 1). Concentrations of inhibitors are the final reaction concentrations. Allopurinol was 
prepared as a saturated aqueous solution. The results shown are a mean of two separate assays which could 
be reproduced within f 10% 
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3. RESULTS 
Enzymic reduction of adriamycin, under partial- 
ly anaerobic conditions, brings about the forma- 
tion of active radicals capable of degrading deox- 
yribose with the release of TBA-reactive products. 
However, when more strict anaerobic conditions 
were secured, using a Thunberg tube, little 
degradation was observed (not shown). 
The effects of including superoxide dismutase, 
catalase or hydroxyl radical scavengers, such as 
mannitol and thiourea, show that the two active 
oxygen intermediates hydrogen peroxide and the 
OH * radical (or species with similar reactivity) are 
essential for the observed degradation of deoxyri- 
bose under nitrogen (tables 1,2). Since hydrogen 
peroxide is not added to the reaction it must be 
formed by the reduction of the dioxygen remaining 
after gassing with nitrogen. This reaction would 
not be inhibited by superoxide dismutase. 
Aerobic reduction of adriamycin does not bring 
about significant deoxyribose degradation within 
the two systems (tables 1, 2). Some 90% of the 
aerobic degradation seen with xanthine oxidase 
cannot be attributed to the presence of adriamycin 
(table 1). It is this adriamycin independent deoxyri- 
bose degradation that is inhibited by superoxide 
dismutase and which has been characterised in 
[ 111. Both the aerobic and partially anaerobic reac- 
tions were inhibited by the specific xanthine oxi- 
dase inhibitor allopurinol. 
The addition of iron-chelators or the iron-bind- 
ing protein transferrin, to reactions carried out in 
air and under nitrogen demonstrated that deoxy- 
ribose degradation requires the presence of traces 
of iron salt (tables 1,2). Saturation of transferrin 
with iron abolished its inhibitory properties. When 
iron salts were added to the various reactions, only 
desferrioxamine inhibited deoxyribose degrada- 
tion under all the conditions studied (fig. 1). 
DETAPAC stimulated deoxyribose degradation at 
low ratios of chelator to iron salt only when 
adriamycin was present (fig. 2). However, EDTA 
stimulated degradation, whether adriamycin was 
present or not only aerobic conditions and over the 
whole range of chelator to iron salt concentrations 
tested (fig. 3). 
Table 2 
Degradation of deoxyribose by adriamycin using the enzyme system ferredoxin reductase and NADPH 
Inhibitors added to the reaction Amount of TBA-reactive material found from deoxy- 
ribose m 1 h (A532) 
In air Under nitrogen 
A532 Inhib. A532 Inhib. 
% % 
Blank 1 (no ferredoxin reductase) 0.08 0.08 
Blank 2 (no adriamycin) 0.05 0.10 
Control (all reagents) 0.15 1.77 
+ EDTA 0.1 mM 0.08 100 0.67 65 
+ DETAPAC 0.1 mM 0.08 100 0.38 82 
+ Desferrioxamine 0.1 mM 0.08 100 0.11 98 
+ Transferrin 0.1 mg/ml 0.08 100 0.15 96 
+ Albumin 0.1 mg/ml 0.20 0 1.68 5 
+ Superoxide dismutase 
(0.05 mg/ml) 0.15 0 1.69 5 
+ Catalase 0.1 mg/ml 0.09 86 0.17 95 
+ Catalase (boiled) 0.24 0 1.70 4 
+ Mannitol 10 mM 0.10 71 0.32 86 
+ Thiourea 1 mM 0.14 14 1.22 33 
The % inhibition is calculated after subtraction of the A532 given by the chromogenic properties of 
adriamycin, (i.e., blank no. 1). Concentrations of inhibitors are the final reaction concentrations. The 
results shown are a mean of two separate assays which could be reproduced within + 10% 
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Fig. 1. Effect of different concentrations (shown as the 
final reaction concentration) of desferrioxamine under 
the conditions described in section 2.1. using xanthine 
oxidase and hypoxanthine. Where indicated, iron salts 
were added as FeC13 to 0.045mM final reaction cont.: 
(A) incubated in air; (A) Fe(III) added, adriamycin 
omitted and incubated in air; (m) Fe(II1) added and 
incubated in air; (0) Fe(II1) added and incubated under 
nitrogen; (0) incubated under nitrogen. 
A532nm 
1.6 
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Fig. 3. Effect of different concentrations (final 
concentrations) of EDTA under the conditions described 
in section 2.1. using xanthine oxidase and hypoxanthine. 
Where indicated, iron salts were added as FeC13 to 
0.045 mM final reaction cont.: (A) incubated in air; (A) 
Fe(II1) added, adriamycin omitted and incubated in air; 
(m) Fe(II1) added and incubated in air; (0) Fe(II1) 
added and incubated under nitrogen; (0) incubated 
under nitrogen. 
Fig. 2. Effect of different concentrations (final reaction 
concentrations) of DETAPAC under the conditions in 
section 2.1. using xanthine oxidase and hypoxanthine. 
Where indicated, iron salts were added as FeCls to a 
0.045 mM final reaction cont.: (A) incubated in air; (A) 
Fe(III) added, adriamycin omitted and incubated in air; 
(m) Fe(II1) added and incubated in air; (0) Fe(III) 
added and incubated under nitrogen; (a) incubated 
under nitrogen. 
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4. DISCUSSION 
TBA-reactivity following free radical damage to 
carbohydrates, amino acids, lipids and nucleic 
acids, has proved to be a sensitive and versatile in- 
direct method for detecting the occurrence of both 
organic and inorganic oxygen radical reactions 
POI. 
Xanthine oxidase transfers electrons directly to 
dioxygen to form superoxide radicals, whereas fer- 
redoxin reductans does not. However, under the 
partially anaerobic conditions described, xanthine 
oxidase and ferredoxin reductase were both able to 
pass electrons directly to adriamycin to form the 
semiquinone radical (Ad’ -). When diogen is pre- 
sent in abundance, electrons are transferred to the 
oxygen molecule to form superoxide radicals 
(0; -). This latter reaction must occur to a limited 
extent under the partially anaerobic conditions to 
account for the formation of the hydrogen 
peroxide: 
20;-+2H++HzOz+Oz (2) 
Superoxide dismutase will not inhibit this reaction, 
it will merely speed up formation of HzOz. The im- 
portance of hydrogen peroxide to the reaction is 
shown by the almost complete inhibition of deoxy- 
ribose degradation following addition of catalase, 
in agreement with studies on methional oxidation 
[3]. Boiled catalase and albumin served as controls 
for the specificity of this reaction. 
In spite of using Chelex resin-treated distilled 
water for preparation of all reagents, iron salts 
were still present at significant levels to influence 
the reactions. Addition of iron salts to the reaction 
changed the behaviour of the iron chelators EDTA 
and DETAPAC but not that of desferrioxamine. 
DETAPAC stimulated deoxyribose damage in air 
and under nitrogen only when adriamycin was pre- 
sent with a low ratio of chelator to iron salt. 
However, EDTA stimulated over all ratios of iron 
salt to chelator only in the presence of air. Similar 
anomalies for these iron chelators have been 
observed during iron-catalysed lipid peroxidation 
WI. 
The enhanced degradation seen under partially 
anaerobic conditions cannot be ascribed simply to 
an ‘iron-catalysed Haber-Weiss reaction’ since 
this should be more effective under aerobic condi- 
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tions. Since adriamycin itself readily complexes 
iron [13, 141 OH’ formation may involve an in 
teraction between hydrogen peroxide and a semi- 
quinone-iron complex. The reaction described is 
clearly complex, and several anomalies have yet to 
be explained. For example, under our reaction con- 
ditions only hypoxanthine, not xanthine, as sub- 
strate led to significant deoxyribose degradation. 
The observation that adriamycin in the presence 
of traces of iron salt (readily available in most 
biological systems) can be more damaging under 
reduced oxygen tensions may be particularly im- 
portant in understanding how certain hypoxic 
tumours might be better treated with such drugs. 
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